Eisai
4523.T
#2660
Rank
C$9.29 B
Marketcap
C$32.96
Share price
1.53%
Change (1 day)
-14.30%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2023: C$0.73 Billion

According to Eisai's latest financial reports the company's current earnings are C$5.06 Billion. In 2023 the company made an earning of C$0.73 Billion, an increase over its 2022 earnings that were of -C$31.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2023

Annual earnings

Year Earnings Change
2023C$0.73 B-2404.04%
2022-C$31.82 Million-103.6%
2021C$0.88 B-39.81%
2020C$1.46 B7.44%
2019C$1.36 B17.22%
2018C$1.16 B86.16%
2017C$0.62 B-23.52%
2016C$0.81 B26.97%
2015C$0.64 B22.3%
2014C$0.52 B-46.07%
2013C$0.97 B-21.85%
2012C$1.25 B-20.59%
2011C$1.57 B-8.91%
2010C$1.73 B19.21%
2009C$1.45 B